162 related articles for article (PubMed ID: 22768321)
1. A Protocol for the secure linking of registries for HPV surveillance.
El Emam K; Samet S; Hu J; Peyton L; Earle C; Jayaraman GC; Wong T; Kantarcioglu M; Dankar F; Essex A
PLoS One; 2012; 7(7):e39915. PubMed ID: 22768321
[TBL] [Abstract][Full Text] [Related]
2. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
3. Population-based enrolment of adolescents in a long-term follow-up trial of human papillomavirus vaccine efficacy.
Lehtinen M; Idänpään-Heikkilä I; Lunnas T; Palmroth J; Barr E; Cacciatore R; Isaksson R; Kekki M; Koskela P; Kosunen E; Kuortti M; Lahti L; Liljamo T; Luostarinen T; Apter D; Pukkala E; Paavonen J
Int J STD AIDS; 2006 Apr; 17(4):237-46. PubMed ID: 16595046
[TBL] [Abstract][Full Text] [Related]
4. The Manitoba human papillomavirus vaccine surveillance and evaluation system.
Kliewer EV; Demers AA; Brisson M; Severini A; Lotocki R; Elias B; Hammond G; Wurtak G;
Health Rep; 2010 Jun; 21(2):37-42. PubMed ID: 20632523
[TBL] [Abstract][Full Text] [Related]
5. Safety of the AS04-adjuvanted human papillomavirus (HPV)-16/18 vaccine in adolescents aged 12-15 years: end-of-study results from a community-randomized study up to 6.5 years.
Bi D; Apter D; Eriksson T; Hokkanen M; Zima J; Damaso S; Soila M; Dubin G; Lehtinen M; Struyf F
Hum Vaccin Immunother; 2020 Jun; 16(6):1392-1403. PubMed ID: 31829767
[TBL] [Abstract][Full Text] [Related]
6. Awareness of human papillomavirus after introduction of HPV vaccination: a large population-based survey of Scandinavian women.
Thomsen LT; Nygård M; Stensen S; Terning Hansen B; Arnheim Dahlström L; Liaw KL; Munk C; Kjaer SK
Eur J Cancer Prev; 2017 Mar; 26(2):170-178. PubMed ID: 27010329
[TBL] [Abstract][Full Text] [Related]
7. A secure protocol for protecting the identity of providers when disclosing data for disease surveillance.
El Emam K; Hu J; Mercer J; Peyton L; Kantarcioglu M; Malin B; Buckeridge D; Samet S; Earle C
J Am Med Inform Assoc; 2011 May; 18(3):212-7. PubMed ID: 21486880
[TBL] [Abstract][Full Text] [Related]
8. Understanding Barriers to HPV Vaccination: Perspectives From Air Force Family Medicine Physicians and Active Duty Air Force Males.
Halista CE; Kline RJ; Bepko J
Mil Med; 2020 Jun; 185(5-6):e878-e886. PubMed ID: 31808930
[TBL] [Abstract][Full Text] [Related]
9. Sources of information for assessing human papillomavirus vaccination history among young women.
Niccolai LM; McBride V; Julian PR;
Vaccine; 2014 May; 32(25):2945-7. PubMed ID: 24713369
[TBL] [Abstract][Full Text] [Related]
10. Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review.
Harder T; Wichmann O; Klug SJ; van der Sande MAB; Wiese-Posselt M
BMC Med; 2018 Jul; 16(1):110. PubMed ID: 30016957
[TBL] [Abstract][Full Text] [Related]
11. Human Papillomavirus Awareness, Vaccine Status, and Risk Factors in Female Emergency Patients.
Walter LA; Leader E; Galbraith JW
West J Emerg Med; 2020 Feb; 21(2):203-208. PubMed ID: 32191177
[TBL] [Abstract][Full Text] [Related]
12. HPV.edu study protocol: a cluster randomised controlled evaluation of education, decisional support and logistical strategies in school-based human papillomavirus (HPV) vaccination of adolescents.
Skinner SR; Davies C; Cooper S; Stoney T; Marshall H; Jones J; Collins J; Hutton H; Parrella A; Zimet G; Regan DG; Whyte P; Brotherton JM; Richmond P; McCaffrey K; Garland SM; Leask J; Kang M; Braunack-Mayer A; Kaldor J; McGeechan K
BMC Public Health; 2015 Sep; 15():896. PubMed ID: 26373926
[TBL] [Abstract][Full Text] [Related]
13. Trends in Human Papillomavirus-Associated Cancers, Demographic Characteristics, and Vaccinations in the US, 2001-2017.
Liao CI; Francoeur AA; Kapp DS; Caesar MAP; Huh WK; Chan JK
JAMA Netw Open; 2022 Mar; 5(3):e222530. PubMed ID: 35294540
[TBL] [Abstract][Full Text] [Related]
14. Active Surveillance of Adverse Events Following Human Papillomavirus Vaccination: Feasibility Pilot Study Based on the Regional Health Care Information Platform in the City of Ningbo, China.
Liu Z; Zhang L; Yang Y; Meng R; Fang T; Dong Y; Li N; Xu G; Zhan S
J Med Internet Res; 2020 Jun; 22(6):e17446. PubMed ID: 32234696
[TBL] [Abstract][Full Text] [Related]
15. Getting to know human papillomavirus (HPV) and the HPV vaccines.
Smith GD; Travis L
J Am Osteopath Assoc; 2011 Mar; 111(3 Suppl 2):S29-34. PubMed ID: 21415377
[TBL] [Abstract][Full Text] [Related]
16. Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study.
Leval A; Herweijer E; Ploner A; Eloranta S; Fridman Simard J; Dillner J; Young C; Netterlid E; Sparén P; Arnheim-Dahlström L
J Natl Cancer Inst; 2013 Apr; 105(7):469-74. PubMed ID: 23486550
[TBL] [Abstract][Full Text] [Related]
17. Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia.
Gertig DM; Brotherton JM; Saville M
Sex Health; 2011 Jun; 8(2):171-8. PubMed ID: 21592430
[TBL] [Abstract][Full Text] [Related]
18. Public health impact and cost-effectiveness of switching from bivalent to nonavalent vaccine for human papillomavirus in Norway: incorporating the full health impact of all HPV-related diseases.
Diakite I; Nguyen S; Sabale U; Pavelyev A; Saxena K; Tajik AA; Wang W; Palmer C
J Med Econ; 2023; 26(1):1085-1098. PubMed ID: 37608730
[TBL] [Abstract][Full Text] [Related]
19. Intent and subsequent initiation of human papillomavirus vaccine among young cancer survivors.
Cherven B; Castellino SM; Chen Y; Wong FL; York JM; Wasilewski-Masker K; Hudson MM; Bhatia S; Klosky JL; Landier W
Cancer; 2019 Nov; 125(21):3810-3817. PubMed ID: 31291010
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus vaccination and anal high-grade precancerous lesions and cancer-a real-world effectiveness study.
Baandrup L; Maltesen T; Dehlendorff C; Kjaer SK
J Natl Cancer Inst; 2024 Feb; 116(2):283-287. PubMed ID: 37718496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
